The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation
Bart L. Scott(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), H. Joachim Deeg(Fred Hutch Cancer Center), Ted Gooley(Fred Hutch Cancer Center), Michael Linenberger(Fred Hutch Cancer Center), Thomas R. Chauncey(City Of Hope National Medical Center), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Andrew R. Rezvani(Stanford Blood Center), Brenda M. Sandmaier(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David Myerson(University of Washington), Jerald P. Radich(University of Washington), Jonathan Grim(Fred Hutch Cancer Center), Mohamed L. Sorror(University of Washington Medical Center)
Cited by 153
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k